MT-2990

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

EndometriosisSeasonal Allergic Rhinitis

199 competitors in Endometriosis

#DrugCompanyPhaseTrials

1

Orilissa

AbbVie

Phase 3

162

Lupron

AbbVie

Phase 3

13

Leuprorelin

Takeda

Phase 3

84

Orgovyx

Sumitomo Pharma America, Inc.

Phase 3

35

Trental

VValidus Pharmaceuticals

Phase 3

16

Estradiol/norethindrone Acetate

AbbVie

Phase 3

57

Triptorelin Embonate

Ipsen

Phase 3

18

Indole-3-Carbinol

UUniversity of Kansas Medical Center

Phase 3

19

Visanne

Bayer

Phase 3

210

Merional

CCairo University

Phase 3

1Show 31 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Drug1 trial

A Clinical Study to Investigate How Safe and Tolerable the Study Drug MT-2990 is and How MT-2990 is Taken up by the Body in Healthy Volunteers

Completed·Tanabe Pharma Corporation·Phase 1·NCT03156738·40 enrolled

Seasonal Allergic Rhinitis1 trial

A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients

Completed·Tanabe Pharma Corporation·Phase 1·NCT03570957·75 enrolled

Endometriosis1 trial

Safety and Efficacy Study of MT-2990 in Women With Endometriosis

Completed·TTanabe Pharma America, Inc.·Phase 2·NCT03840993·76 enrolled

Unspecified1 trial

An Exploratory Study of MT-2990 in Patients With AAV

Completed·Tanabe Pharma Corporation·Phase 1·NCT06196905·5 enrolled

Details

Drug Info

Related News